Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy

NCT01487304 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3760

Last updated 2016-10-17

No results posted yet for this study

Summary

This study is conducted in Europe. The aim of this study is to verify the therapeutic effects of low-dose hormone replacement therapy (HRT) in female patients over adequately long time period in normal clinical practice conditions in the Czech Republic.

Conditions

  • Menopause
  • Hormone Replacement Therapy, Post-Menopausal

Interventions

DRUG

Marketed low dose hormone replacement therapy

A low dose of marketed HRT products prescribed at the discretion of the treating physician

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01487304 on ClinicalTrials.gov